Industry: Chemical & Material
Published Date: 2025-05-29
Pages: 79 Pages
Report ld: 4746696
Request Sample
Customized Report
Recombinant Homocysteine Methyltransferase Market Size(US$)

CAGR 2025-2031
6.6%
Market Size,2031
USD 397
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Recombinant Homocysteine Methyltransferase market size was US$ 241 million in 2024 and is forecast to a readjusted size of US$ 397 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Recombinant Homocysteine Methyltransferase market competitiveness, regional economic performance, and supply chain configurations.
Recombinant homocysteine methyltransferase is a key metabolic enzyme expressed through genetic engineering technology. It catalyzes the methylation of homocysteine to produce methionine and participates in the folate cycle and methylation reaction. This enzyme plays an important role in the pathological mechanism of cardiovascular disease, neurodegenerative diseases and birth defects, and is widely used in in vitro diagnostic reagents, drug development and scientific research. Recombinant RHMT has high purity, high activity and stability, and is usually stored in lyophilized powder or liquid form. It must meet GMP standards to meet clinical and industrial needs.
The North America Recombinant Homocysteine Methyltransferase market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Recombinant Homocysteine Methyltransferase include Creative Enzymes, Biomatik, Gentaur, ZEYE, R&D Systems, KinesisDx, Seebio, DESHENG MATERIALS, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Recombinant Homocysteine Methyltransferase market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Recombinant Homocysteine Methyltransferase market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Polymeric Enzymes in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Scientific Research Field in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Recombinant Homocysteine Methyltransferase value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Recombinant Homocysteine Methyltransferase Product Scope
1.2 Recombinant Homocysteine Methyltransferase by Type
1.2.1 Global Recombinant Homocysteine Methyltransferase Sales by Type (2020 & 2024 & 2031)
1.2.2 Monomeric Enzymes
1.2.3 Polymeric Enzymes
1.3 Recombinant Homocysteine Methyltransferase by Application
1.3.1 Global Recombinant Homocysteine Methyltransferase Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Medical Field
1.3.3 Scientific Research Field
1.4 Global Recombinant Homocysteine Methyltransferase Market Estimates and Forecasts (2020-2031)
1.4.1 Global Recombinant Homocysteine Methyltransferase Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Recombinant Homocysteine Methyltransferase Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Recombinant Homocysteine Methyltransferase Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Recombinant Homocysteine Methyltransferase Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Recombinant Homocysteine Methyltransferase Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Recombinant Homocysteine Methyltransferase Sales Market Share by Region (2020-2025)
2.2.2 Global Recombinant Homocysteine Methyltransferase Revenue Market Share by Region (2020-2025)
2.3 Global Recombinant Homocysteine Methyltransferase Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Recombinant Homocysteine Methyltransferase Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Recombinant Homocysteine Methyltransferase Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Recombinant Homocysteine Methyltransferase Market Size and Prospective (2020-2031)
2.4.2 Europe Recombinant Homocysteine Methyltransferase Market Size and Prospective (2020-2031)
2.4.3 China Recombinant Homocysteine Methyltransferase Market Size and Prospective (2020-2031)
2.4.4 Japan Recombinant Homocysteine Methyltransferase Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Recombinant Homocysteine Methyltransferase Historic Market Review by Type (2020-2025)
3.1.1 Global Recombinant Homocysteine Methyltransferase Sales by Type (2020-2025)
3.1.2 Global Recombinant Homocysteine Methyltransferase Revenue by Type (2020-2025)
3.1.3 Global Recombinant Homocysteine Methyltransferase Price by Type (2020-2025)
3.2 Global Recombinant Homocysteine Methyltransferase Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Recombinant Homocysteine Methyltransferase Sales Forecast by Type (2026-2031)
3.2.2 Global Recombinant Homocysteine Methyltransferase Revenue Forecast by Type (2026-2031)
3.2.3 Global Recombinant Homocysteine Methyltransferase Price Forecast by Type (2026-2031)
3.3 Different Types Recombinant Homocysteine Methyltransferase Representative Players
4 Global Market Size by Application
4.1 Global Recombinant Homocysteine Methyltransferase Historic Market Review by Application (2020-2025)
4.1.1 Global Recombinant Homocysteine Methyltransferase Sales by Application (2020-2025)
4.1.2 Global Recombinant Homocysteine Methyltransferase Revenue by Application (2020-2025)
4.1.3 Global Recombinant Homocysteine Methyltransferase Price by Application (2020-2025)
4.2 Global Recombinant Homocysteine Methyltransferase Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Recombinant Homocysteine Methyltransferase Sales Forecast by Application (2026-2031)
4.2.2 Global Recombinant Homocysteine Methyltransferase Revenue Forecast by Application (2026-2031)
4.2.3 Global Recombinant Homocysteine Methyltransferase Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Recombinant Homocysteine Methyltransferase Application
5 Competition Landscape by Players
5.1 Global Recombinant Homocysteine Methyltransferase Sales by Players (2020-2025)
5.2 Global Top Recombinant Homocysteine Methyltransferase Players by Revenue (2020-2025)
5.3 Global Recombinant Homocysteine Methyltransferase Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Homocysteine Methyltransferase as of 2024)
5.4 Global Recombinant Homocysteine Methyltransferase Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Recombinant Homocysteine Methyltransferase, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Recombinant Homocysteine Methyltransferase, Product Type & Application
5.7 Global Key Manufacturers of Recombinant Homocysteine Methyltransferase, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Recombinant Homocysteine Methyltransferase Sales by Company
6.1.1.1 North America Recombinant Homocysteine Methyltransferase Sales by Company (2020-2025)
6.1.1.2 North America Recombinant Homocysteine Methyltransferase Revenue by Company (2020-2025)
6.1.2 North America Recombinant Homocysteine Methyltransferase Sales Breakdown by Type (2020-2025)
6.1.3 North America Recombinant Homocysteine Methyltransferase Sales Breakdown by Application (2020-2025)
6.1.4 North America Recombinant Homocysteine Methyltransferase Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Recombinant Homocysteine Methyltransferase Sales by Company
6.2.1.1 Europe Recombinant Homocysteine Methyltransferase Sales by Company (2020-2025)
6.2.1.2 Europe Recombinant Homocysteine Methyltransferase Revenue by Company (2020-2025)
6.2.2 Europe Recombinant Homocysteine Methyltransferase Sales Breakdown by Type (2020-2025)
6.2.3 Europe Recombinant Homocysteine Methyltransferase Sales Breakdown by Application (2020-2025)
6.2.4 Europe Recombinant Homocysteine Methyltransferase Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Recombinant Homocysteine Methyltransferase Sales by Company
6.3.1.1 China Recombinant Homocysteine Methyltransferase Sales by Company (2020-2025)
6.3.1.2 China Recombinant Homocysteine Methyltransferase Revenue by Company (2020-2025)
6.3.2 China Recombinant Homocysteine Methyltransferase Sales Breakdown by Type (2020-2025)
6.3.3 China Recombinant Homocysteine Methyltransferase Sales Breakdown by Application (2020-2025)
6.3.4 China Recombinant Homocysteine Methyltransferase Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Recombinant Homocysteine Methyltransferase Sales by Company
6.4.1.1 Japan Recombinant Homocysteine Methyltransferase Sales by Company (2020-2025)
6.4.1.2 Japan Recombinant Homocysteine Methyltransferase Revenue by Company (2020-2025)
6.4.2 Japan Recombinant Homocysteine Methyltransferase Sales Breakdown by Type (2020-2025)
6.4.3 Japan Recombinant Homocysteine Methyltransferase Sales Breakdown by Application (2020-2025)
6.4.4 Japan Recombinant Homocysteine Methyltransferase Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Creative Enzymes
7.1.1 Creative Enzymes Company Information
7.1.2 Creative Enzymes Business Overview
7.1.3 Creative Enzymes Recombinant Homocysteine Methyltransferase Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Creative Enzymes Recombinant Homocysteine Methyltransferase Products Offered
7.1.5 Creative Enzymes Recent Development
7.2 Biomatik
7.2.1 Biomatik Company Information
7.2.2 Biomatik Business Overview
7.2.3 Biomatik Recombinant Homocysteine Methyltransferase Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Biomatik Recombinant Homocysteine Methyltransferase Products Offered
7.2.5 Biomatik Recent Development
7.3 Gentaur
7.3.1 Gentaur Company Information
7.3.2 Gentaur Business Overview
7.3.3 Gentaur Recombinant Homocysteine Methyltransferase Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Gentaur Recombinant Homocysteine Methyltransferase Products Offered
7.3.5 Gentaur Recent Development
7.4 ZEYE
7.4.1 ZEYE Company Information
7.4.2 ZEYE Business Overview
7.4.3 ZEYE Recombinant Homocysteine Methyltransferase Sales, Revenue and Gross Margin (2020-2025)
7.4.4 ZEYE Recombinant Homocysteine Methyltransferase Products Offered
7.4.5 ZEYE Recent Development
7.5 R&D Systems
7.5.1 R&D Systems Company Information
7.5.2 R&D Systems Business Overview
7.5.3 R&D Systems Recombinant Homocysteine Methyltransferase Sales, Revenue and Gross Margin (2020-2025)
7.5.4 R&D Systems Recombinant Homocysteine Methyltransferase Products Offered
7.5.5 R&D Systems Recent Development
7.6 KinesisDx
7.6.1 KinesisDx Company Information
7.6.2 KinesisDx Business Overview
7.6.3 KinesisDx Recombinant Homocysteine Methyltransferase Sales, Revenue and Gross Margin (2020-2025)
7.6.4 KinesisDx Recombinant Homocysteine Methyltransferase Products Offered
7.6.5 KinesisDx Recent Development
7.7 Seebio
7.7.1 Seebio Company Information
7.7.2 Seebio Business Overview
7.7.3 Seebio Recombinant Homocysteine Methyltransferase Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Seebio Recombinant Homocysteine Methyltransferase Products Offered
7.7.5 Seebio Recent Development
7.8 DESHENG MATERIALS
7.8.1 DESHENG MATERIALS Company Information
7.8.2 DESHENG MATERIALS Business Overview
7.8.3 DESHENG MATERIALS Recombinant Homocysteine Methyltransferase Sales, Revenue and Gross Margin (2020-2025)
7.8.4 DESHENG MATERIALS Recombinant Homocysteine Methyltransferase Products Offered
7.8.5 DESHENG MATERIALS Recent Development
8 Recombinant Homocysteine Methyltransferase Manufacturing Cost Analysis
8.1 Recombinant Homocysteine Methyltransferase Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Recombinant Homocysteine Methyltransferase
8.4 Recombinant Homocysteine Methyltransferase Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Recombinant Homocysteine Methyltransferase Distributors List
9.3 Recombinant Homocysteine Methyltransferase Customers
10 Recombinant Homocysteine Methyltransferase Market Dynamics
10.1 Recombinant Homocysteine Methyltransferase Industry Trends
10.2 Recombinant Homocysteine Methyltransferase Market Drivers
10.3 Recombinant Homocysteine Methyltransferase Market Challenges
10.4 Recombinant Homocysteine Methyltransferase Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Recombinant Homocysteine Methyltransferase market is projected to grow from US$ 270 million in 2025 to US$ 421 million by 2032, at a CAGR of 6.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 148
USD 4900.00
(Single User License)
The global Recombinant Homocysteine Methyltransferase market was valued at US$ 270 million in 2025 and is anticipated to reach US$ 421 million by 2032, at a CAGR of 6.6% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 133
USD 2900.00
(Single User License)
The global Recombinant Homocysteine Methyltransferase market size was US$ 270 million in 2025 and is forecast to reach a readjusted size of US$ 421 million by 2032 with a CAGR of 6.6% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 77
USD 4250.00
(Single User License)
The global market for Recombinant Homocysteine Methyltransferase was estimated to be worth US$ 270 million in 2025 and is projected to reach US$ 421 million, growing at a CAGR of 6.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 109
USD 3950.00
(Single User License)
The global market for Recombinant Homocysteine Methyltransferase was valued at US$ 241 million in the year 2024 and is projected to reach a revised size of US$ 397 million by 2031, growing at a CAGR of 6.6% during the forecast period.
Published Date: 2025-05-29
Pages: 94
USD 2900.00
(Single User License)
The global market for Recombinant Homocysteine Methyltransferase was estimated to be worth US$ 241 million in 2024 and is forecast to a readjusted size of US$ 397 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Published Date: 2025-05-29
Pages: 98
USD 3950.00
(Single User License)
The global Recombinant Homocysteine Methyltransferase market is projected to grow from US$ 270 million in 2025 to US$ 397 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period.
Published Date: 2025-05-29
Pages: 138
USD 4900.00
(Single User License)
The global Recombinant Homocysteine Methyltransferase market is projected to grow from US$ 270 million in 2025 to US$ 421 million by 2032, at a CAGR of 6.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 148
The global Recombinant Homocysteine Methyltransferase market was valued at US$ 270 million in 2025 and is anticipated to reach US$ 421 million by 2032, at a CAGR of 6.6% from 2026 to 2032.
Published: 2026-03-11
Pages: 133
The global Recombinant Homocysteine Methyltransferase market size was US$ 270 million in 2025 and is forecast to reach a readjusted size of US$ 421 million by 2032 with a CAGR of 6.6% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 77
The global market for Recombinant Homocysteine Methyltransferase was estimated to be worth US$ 270 million in 2025 and is projected to reach US$ 421 million, growing at a CAGR of 6.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 109
The global market for Recombinant Homocysteine Methyltransferase was valued at US$ 241 million in the year 2024 and is projected to reach a revised size of US$ 397 million by 2031, growing at a CAGR of 6.6% during the forecast period.
Published: 2025-05-29
Pages: 94
The global market for Recombinant Homocysteine Methyltransferase was estimated to be worth US$ 241 million in 2024 and is forecast to a readjusted size of US$ 397 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Published: 2025-05-29
Pages: 98
The global Recombinant Homocysteine Methyltransferase market is projected to grow from US$ 270 million in 2025 to US$ 397 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period.
Published: 2025-05-29
Pages: 138
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now